Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies
Authors
Keywords
-
Journal
ULTRASOUND IN OBSTETRICS & GYNECOLOGY
Volume 45, Issue 3, Pages 286-293
Publisher
Wiley
Online
2014-12-10
DOI
10.1002/uog.14760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New Gestational Phase–Specific Cutoff Values for the Use of the Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor Ratio as a Diagnostic Test for Preeclampsia
- (2013) Stefan Verlohren et al. HYPERTENSION
- Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders
- (2013) Theresa Engels et al. HYPERTENSION IN PREGNANCY
- Angiogenic growth factors in maternal and fetal serum in concordant and discordant twin pregnancies
- (2013) Nerea Ruiz-Sacedón et al. Journal of Maternal-Fetal & Neonatal Medicine
- First trimester maternal serum placental growth factor levels in twin pregnancies
- (2013) Nicholas J. Cowans et al. PRENATAL DIAGNOSIS
- Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia
- (2012) Sarosh Rana et al. CIRCULATION
- Circulating Angiogenic Factors and Risk of Adverse Maternal and Perinatal Outcomes in Twin Pregnancies With Suspected Preeclampsia
- (2012) Sarosh Rana et al. HYPERTENSION
- Risk factors for preeclampsia in twin pregnancies: a population-based matched case-control study
- (2012) Miha Lučovnik et al. JOURNAL OF PERINATAL MEDICINE
- Epidemiology of Twinning in Developed Countries
- (2012) Cande V. Ananth et al. SEMINARS IN PERINATOLOGY
- The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
- (2011) Stefan Verlohren et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Preeclampsia, a Disease of the Maternal Endothelium
- (2011) Camille E. Powe et al. CIRCULATION
- First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology
- (2011) O. Sanchez et al. HUMAN REPRODUCTION
- Twins: prevalence, problems, and preterm births
- (2010) Suneet P. Chauhan et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies
- (2010) Robert W. Powers et al. PLoS One
- An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
- (2009) Stefan Verlohren et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The aged uterus: multifetal pregnancy outcome after ovum donation in older women
- (2009) M. J. Simchen et al. HUMAN REPRODUCTION
- Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
- (2008) Yuval Bdolah et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
- (2008) Roberto Romero et al. Journal of Maternal-Fetal & Neonatal Medicine
- The Two Stage Model of Preeclampsia: Variations on the Theme
- (2008) J.M. Roberts et al. PLACENTA
- Placental Expression of Soluble fms-Like Tyrosine Kinase 1 is Increased in Singletons and Twin Pregnancies with Intrauterine Growth Restriction
- (2007) Ori Nevo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started